5,7,3',4'-tetrahydroxy-2-(3,3-dimethylallyl) isoflavone for COVID-19

 5,7,3',4'-tetrahydroxy-2-(3,3-dimethylallyl) isoflavone has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed 5,7,3',4'-tetrahydroxy-2-(3,3-dimethylallyl) isoflavone in detail.
Kumar et al., COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery, Genes & Diseases, doi:10.1016/j.gendis.2022.12.019